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Abstract: Galectin-1 (GAL-1) belongs to the family of β-galactoside-binding lectins. It regulates cell-cell and cell-
matrix interactions, the immune response, apoptosis, cell cycle, RNA splicing and neoplastic transformation. We 
investigate the effect of heart manipulation secondary to cardiac surgery on the level of GAL-1 in murine heart 
and plasma. Male C57B6/J mice were used for adopted model of cardiac surgery. Heart samples were processed 
for immunohistochemical and immunofluorescent labeling, Enzyme linked immunosorbent assay and quantitative 
RT-PCR to identify GAL-1 levels in the heart and plasma during the first 24 hours following cardiac surgery. There 
is significant increase of GAL-1 in the LV at 30  minutes (P<0.000), 60 minutes (P<0.001), 4 hour (P<0.003), and 
24 hour (P<0.003) time points of surgically operated groups compared to non-operated control group, while GAL-1 
mRNA levels in any of the surgically operated groups are not significantly different from the non-operated group sug-
gesting extracardiac origin of this raise of GAL-1. There is significant increase of GAL-1 in the plasma at 30  minutes 
(P<0.000), 60 minutes (P<0.009), 4 hour (P<0.043), and 24 hour (P<0.000) time points of surgically operated 
groups compared to non-operated control group. In conclusion, GAL-1 is valuable biomarker of surgical stress.
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Introduction
Galectin-1 (GAL-1) belongs to the family of 
β-galactoside-binding lectins [1]. GAL-1 is a 
14.5-kDa protein which forms lattice-like com-
plexes with receptors that participate in recog-
nition of cell-matrix [2-5]. GAL-1 regulates cell-
cell and cell-matrix interactions, the immune 
response, apoptosis, cell cycle, RNA splicing 
and neoplastic transformation [5-11]. Intra- 
cellular GAL-1 has been shown to be present 
mainly in cells cytosol and less likely in nuclei 
depending upon various types and conditions 
of the cells [12]. GAL-1 is endogenous to the 
heart but its upregulation in the myocardium 
has been reported in literature following myo-
cardial infarction [13, 14]. Surgical stress is the 
body reaction to surgical manipulation and 
characterized by activation of the sympathetic 
nervous system, endocrine responses as well 
as immunological and haematological changes 
leading to disturbances of metabolic and physi-
ological processes that induce changes in the 
acute phase, inflammatory, hormonal, and 
genomic responses of the body [15]. Open-
heart surgical procedures are associated with 
an inflammatory response that is largely the 
result of surgical trauma [16, 17]. In this study 
we investigate the effect of heart manipulation 
secondary to cardiac surgery on the level of 
GAL-1 in murine heart and plasma.
Material and methods
Animal groups
Male C57B6/J mice were used for the surgical 
procedure for the following time points: 30 min-
utes, 60 minutes, 4- hour and 24- hour post 
operation. Samples from non-operated animals 
(Naïve) were also studied. The Animal Research 
Ethics Committee of the College of Medicine 
and Health Sciences, UAE University have 
approved all experimental procedures; Protocol 
No.A12/10.
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Murine surgical procedure
C57B6/J mice (male, age: 12-16 weeks; wt: 
20-25 g) were anesthetized by an intraperito-
neal injection of a combination of Ketamine 
(100 mg/kg) and Xylazine (10 mg/kg). The mice 
were then intubated and ventilated. We adopt a 
mouse model similar to open-heart surgery to 
fulfill the requirements for inclusion criteria of 
this project. The inclusion criteria includes 
opening of the chest wall, removal of pericardi-
um, and one passing a stitch needle in the left 
ventricle (LV) and taking it out in intubated ven-
tilated anaesthetized mice to be followed by 
closure of chest and skin and scarification at 
30 minutes, 60 minutes, 4- hour and 24- hour 
postoperatively. The adopted surgical proce-
dure is similar to the sham myocardial infarc-
tion surgery done on the mice as described 
elsewhere [18-20].
Briefly, the chest was opened with a lateral inci-
sion at the 4th intercostal space on the left side 
of the sternum and the chest wall was retract-
4-0 prolene suture. The animal was gently dis-
connected from the ventilator and spontane-
ous breathing was seen immediately. Pos- 
toperative analgesic (Butorphanol 2 mg/kg, 
s/c, 6 hourly) was given at the end of the proce-
dure. According to the experimental protocol 
mice were sacrificed at desired time points. 
Blood was collected in EDTA vacutainers and 
the heart was resected, washed in ice cold 
phosphate buffered saline (PBS), the right ven-
tricle and both atria were dissected away and 
LV was immediately frozen in liquid nitrogen 
and later stored in -80°C freezer. Collected 
blood was centrifuged at 3000 RPM for 15 min-
utes. The plasma was collected, alliquoted and 
stored at -80°C until further analysis. Heart 
samples from the same time points were also 
fixed in 10% buffered formal-saline for 24 
hours. Heart samples from the same time 
points were also fixed in 10% buffered formal-
saline for 24 hours and in RNA stabilization 
solution to be processed later.
RNA isolation and quantitative reverse tran-
scriptase PCR
The mouse LV heart samples were homoge-
nized in TRI Reagent (Ambion), and RNA was 
isolated by phenol-chloroform method [21]. 
RNA pellet was resuspended in nuclease-free 
water and stored at -80°C. RNA was quantified 
using a NanoDrop spectrophotometer and 
reverse transcribed using High-Capacity cDNA 
Reverse Transcription kit (Part #4368814, PN 
4374967; Applied Biosystems Inc, Foster City, 
CA, USA) according to the recommended proto-
col. cDNA was diluted 1:10 and amplified by 
real-time PCR using target-specific TaqMan 
gene expression assays using the 7500 Real- 
Time PCR system (Applied Biosystems). Each 
well was run in duplicate for gene of interest 
and reference primer 18S rRNA (Applied 
Biosystems). The primers and probes for 
Table 1. Galectin-1 levels in ng/mg of total protein at different 
time points after surgical operation
Groups N Mean (ng/mg) Std Dev Std Error P value
Non-operated control 6 68.21 12.42 5.07
30 min post surgery 6 116.75 18.76 7.66 0.000*
60 min post surgery 6 93.35 6.42 2.62 0.001*
4 hours post surgery 6 92.28 8.78 3.58 0.003*
24 hours post surgery 6 88.28 3.03 1.24 0.003*
*Shows P<0.05 in surgically operated vs non-operated control groups.
Figure 1. Graphical representation of the Galectin-1 
levels in the LV at different post operated time points. 
*Shows P<0.05 in non-operated control vs surgically 
operated groups.
ed. The pericardial sac was 
removed and an 8-0 silk suture 
was passed in the myocardium at 
the anterior surface of the heart 
for one second and then removed. 
The chest wall then was closed 
by approximating the third and 
fourth ribs with one or two inter-
rupted sutures, the muscles 
returned back to their original 
position and the skin closed with 
Galectin-1 in surgical stress
7159 Int J Clin Exp Pathol 2015;8(6):7157-7164
Figure 2. Galectin-1 in the heart. A. Low power view of heart from non-operated control group showing low and 
patchy expression of GAL-1, mainly in the right ventricle (arrow head) and interventricular septum (thin arrow), Im-
munoperoxidase streptavidin-biotin method. B. High power view of left ventricle tissue from non-operated control 
group showing spotty low expression of GAL-1 mainly in endothelial cells (arrow head) and cardiomyocytes sarco-
Galectin-1 in surgical stress
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GAL-1 (Mm00839408_g1) and 18S rRNA 
(Mm03928990_g1) were purchased from 
Applied Biosystems. Data acquisition was done 
by using 7500 software v2.0.6 (Applied 
Biosystems). Analysis was carried out using the 
comparative Ct method. The level of GAL-1 
expression was normalized to 18S rRNA, and 
fold changes were calculated relative to expres-
sion in sham-operated LV heart tissue using 
the formula 2-ΔΔCt. Many aspects of Minimum 
Information for Publication of Quantitative Real-
Time PCR Experiments guidelines were taken 
into consideration for methods and analysis 
[22].
Sample processing for protein extraction
Total protein was extracted from heart samples 
by homogenizing on ice and then centrifugation 
at 14000 RPM for 15 minutes at 4°C. Su- 
pernatant was collected, alliquoted and stored 
Immunohistochemistry
Five- μm sections were cut, dewaxed and rehy-
drated with graded alcohol. Pre-treatment pro-
cedure to unmask the antigens was performed 
in a microwave oven for 10 minutes. Sections 
were incubated overnight with anti- GAL-1 (rab-
bit antimouse polyclonal antibody 1:2500, 
Davids Biotechnologie GmbH, Germany) anti-
bodies at 4°C. After conjugation with primary 
antibodies, sections were incubated with bio-
tin-labeled secondary antibody (Thermo 
Scientific, USA) for 20 minutes at room temper-
ature. Finally, sections were incubated with 
streptavidin-peroxidase complex for 20 min-
utes at room temperature (Thermo Scientific, 
USA), DAB chromogen (Thermo Scientific, USA) 
added and counter staining done with haema-
toxylin. Appropriate positive and negative con-
trols were used.
lemmal membrane (thin arrow), Immunoperoxidase streptavidin-biotin method. C. High power view of left ventricle 
tissue from non-operated control group showing spotty low expression of GAL-1 mainly in endothelial cells (arrow 
head) and cardiomyocytes sarcolemmal membrane (thin arrow) giving a mesh-like pattern, Alexa Fluor 488, im-
munofluorescent technique. D, G, J, M. Low power views of heart from surgically operated groups at 30 min, 60 
min, 4 hour, 24 hour post-operatively time points showing higher patchy expression of GAL-1in the left ventricle 
and interventricular septum (thin arrow), the right ventricle is also showing expression of GAL-1 (arrow head), Im-
munoperoxidase streptavidin-biotin method. E, H, K, N. High power views of left ventricle from surgically operated 
groups at 30 min, 60 min, 4 hour, 24 hour post-operatively time points showing higher patchy expression of GAL-1 
in cardiomyocytes (thin arrow) and endothelial cells (arrow head), Immunoperoxidase streptavidin-biotin method. F, 
I, L, O. High power views of left ventricle from surgically operated groups at 30 min, 60 min, 4 hour, 24 hour post-
operatively time points showing higher patchy expression of GAL-1 in cardiomyocytes (thin arrow) and endothelial 
cells (arrow head) of left ventricle, Alexa Fluor 488, immunofluorescent technique.
Table 2. GAL-1 mRNA fold expression in the left ventricle following 
surgery
Groups N Mean mRNA Fold Expression Std Dev Std Error P value
Non-operated control 6 1.041 0.31 0.12
30 min post surgery 6 0.78 0.27 0.11 0.15
60 min post surgery 6 1.23 0.25 0.10 0.26
4 hours post surgery 6 1.32 0.22 0.09 0.11
24 hours post surgery 6 0.95 0.13 0.05 0.50
Table 3. Plasma Galectin-1 levels in ng/ml at different time points 
after sham operation
Groups N Mean (ng/ml) Std Dev Std  Error P value
Non-operated control 6 8.71 2.04 0.83
30 min post surgery 8 14.52 2.21 0.74 0.000*
60 min post surgery 8 13.83 3.92 1.38 0.009*
4 hours post surgery 6 10.64 2.51 1.02 0.043*
24 hours post surgery 6 17.86 2.63 0.93 0.000*
*Shows P<0.05 in surgically operated vs non-operated control groups.
at -80°C until further analy- 
sis. Total protein concentration 
was determined by BCA pro-
tein assay method (Thermo 
Scientific Pierce BCA Protein 
Assay Kit).
Sample processing for histol-
ogy
Each heart was sectioned, 
casseted and fixed directly in 
10% buffered formalin. Sec- 
tions were dehydrated in in- 
creasing concentrations of eth-
anol, cleared with xylene and 
embedded with paraffin. Th- 
ree-μm sections were prepa- 
red from paraffin blocks and 
stained with haematoxylin and 
eosin. The stained sections 
were evaluated by the histopa-
thologist that participated in 
this project.
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Immunofluorescent labeling
5 µm sections were deparaffinized and rehy-
drated with graded alcohol. Sections were 
placed in EnVision™ FLEX Target Retrieval 
Solution with a high PH (PH 9) (DAKO Cy- 
tomation, Denmark) in a water bath at 80°C for 
one hour. Later they were incubated with anti-
GAL-1 (rabbit anti-mouse polyclonal antibody 
1:50, Davids Biotechnologie GmbH, Germany) 
overnight at room temperature. Sections were 
subsequently incubated with Donkey anti-rab-
bit Alexa Fluor 488, (Invitrogen, USA, 1: 50). 
Finally, sections were mounted in water-soluble 
mounting media and viewed with Olympus 
Fluorescent microscope.
Enzyme linked immunosorbent assay
Left ventricular myocardial and plasma concen-
tration of GAL-1 was determined using DuoSet 
enzyme linked immunosorbent assay (ELISA) Deve- 
lopment kit (R&D Systems, Minneapolis, MN, 
USA) for sandwich ELISA, using standard proce-
dure according to the manufacturer’s instruc- 
tions.
Statistical analysis
Statistical analysis is done using IBM SPSS 
Statistics version 20. Data are presented in 
mean ± S.E. Statistically significant differences 
(P<0.05) were calculated between each surgi-
cally operated group and the non- operated 
naïve group by students t test.
Results
Galectin-1 in response to surgical stress in the 
heart
GAL-1 concentration in LV tissue of non-operat-
ed control animal group was measured to be 
66.32±4.69 ng/mg. GAL-1 concentration in LV 
tissue of surgically operated mice at different 
time points of surgical stress are presented in 
Table 1. There is significant increase of GAL-1 in 
LV at all tested time points compared to non-
operated control group (Figure 1). In normal 
heart, GAL-1 is mainly seen to be expressed by 
cardiomyocytes and endothelial cells (Figure 
2A-C). The expression is more pronounced in 
the right ventricle as compared to the left ven-
tricle (Figure 2A). In the LV, GAL-1 is mainly 
expressed by endothelial cells and few cardio-
myocytes (Figure 2C). A very characteristic 
staining pattern is seen in immunofluorescent 
labeling of GAL-1, which gives a mesh-like stain-
ing pattern of myocardium. While in the surgical 
operated groups at 30 minute, 60 minute, 4 
hour and 24 hour time points, we have increase 
in the expression of GAL-1 by cardiomyocytes 
and endothelial cells in the LV (Figure 2F-O) as 
compared to the non-operated group (Figure 
2A-C)
GAL-1 mRNA expression in post surgery 
groups
GAL-1 mRNA levels in all surgically operated 
groups are not significantly different from the 
non-operated group (Table 2).
Plasma Galectin-1 in response to surgical 
stress: The concentration of GAL-1 in plasma of 
non-operated control animals was measured to 
be 8.71 ng/ml. The level of GAL-1 in surgically 
operated groups is shown in Table 3. There are 
significant higher levels of GAL-1 in the surgi-
cally operated groups compared to the non-
operated controls (Figure 3).
Discussion
The major observation in this study is that 
GAL-1 levels in the heart and plasma are signifi-
cantly raised in response to cardiac surgeries 
in mice. Our adopted murine model of cardiac 
surgery includes thoracotomy, pericardiectomy 
and a minor surgical injury to the LV tissue 
induced by passing the stitch needle once in 
Figure 3. Graphical representation of the Galectin-1 
levels in the plasma at different post operated time 
points. *Shows P<0.05 in non-operated control vs 
surgically operated groups.
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the LV. The observed increase in GAL-1 levels in 
the plasma and heart tissue suggests that 
GAL-1 may be part of the surgical stress 
response proteins.
It is well known that surgical trauma results in 
derangements of metabolic and physiological 
processes that can disrupt the inflammatory, 
acute phase, hormonal, and genomic respons-
es [15]. Surgical stress response is triggered by 
the nervous system that sends impulses from 
the injured site to the hypothalamus. The hypo-
thalamus either stimulates or inhibits the 
release of pituitary hormones. Pituitary hor-
mones induce the release of the stress hor-
mone, cortisol [23]. Cortisol, glucagon, cate-
cholamines, and some inflammatory cytokines 
are the major players in the stress response to 
surgery. They are responsible for tachycardia, 
nervousness and hypermetabolic state, which 
itself lead to increased stress on the heart. 
Open heart surgery is associated with acute 
perioperative changes in plasma levels of corti-
sol [24].
GAL-1 has been linked to stress in a research 
study by Iwamoto et al. [25]. In this study GAL-1 
levels in the serum were found to be significant-
ly higher in animals subjected to stress by 
restraining the animals. The pattern of change 
was found to be similar to that of corticoste-
rone. A very interesting observation made in 
the same study was that the increase of GAL-1 
was prevented by a neurotoxin, 6-hydroxydopa-
mine (6-OHDA), which destroys the noradrener-
gic nerve terminals, suggesting that the stress-
induced increase of GAL-1 is regulated by the 
sympathetic nervous system.
The heart is densely innervated by sympathetic 
nerve fibers [26]. The increase in GAL-1 levels 
in the LV tissue of the operated group may be 
due to the general effect of sympathetic stimu-
lation of the nerve terminal of the heart in 
response to surgery. This idea is further sup-
ported by the fact that we observed no changes 
in LV GAL-1 mRNA levels between non-operated 
control group and all the postoperative groups. 
This suggests that the initial increase in GAL-1 
in heart tissue and subsequently the plasma 
may not be due to the GAL-1 transcribed in the 
heart tissue but due to GAL-1 production by the 
sympathetic nerve endings in the heart.
In surgically operated groups, we observed that 
GAL-1 immunoreactivity was focally increased 
in the cytoplasm of cardiomyocytes in the LV.  In 
this case the increase in GAL-1 can be due to 
the effect of injury to the myocardium sustained 
during the operation. Also the effect of pericar-
diectomy and thoracotomy on the heart and 
plasma should be taken into account. The idea 
of increase GAL-1 at the site of injury is not new. 
GAL-1 was found to be increased at the site of 
skeletal muscle injury [27]. GAL-1 can promote 
both myoblast fusion and axonal growth follow-
ing muscle injury and play a role in regenerating 
skeletal muscles. Immunostaining analysis of 
GAL-1 in injured spinal cords also showed GAL-1 
-expressing cells assembled around the lesion 
site [28]. We propose therefore, that the 
increase in GAL-1 levels in the heart may partly 
be due to the focal injury to the cardiomyocytes 
and partly due to the sympathetic stimulation 
of the heart as part of the surgical stress 
response.
The pattern of GAL-1 levels at different time 
points following cardiac surgery is also very 
important. We have seen a sharp increase in 
GAL-1 levels after 30 minutes post operatively 
and later remains elevated, but towards the 24 
hour time point it starts going down. This pat-
tern also points towards GAL-1 as an acute 
stress player which increases in concentration 
locally immediately following injury but as the 
body’s homeostatic mechanism takes effect its 
level starts to come down. However, we do not 
see the same pattern in the plasma where we 
have observed higher levels at 24 hours post 
operation. A possible explanation for this phe-
nomenon may be related to the fact that GAL-1 
is expressed in activated T-Cells [29] and major 
surgery is one factor that enhances the early 
phase of T lymphocyte activation [30] which 
may have led to this increase in plasma GAL-1 
at 24 hours postoperatively.
We believe that there should be a purpose for 
this rise in GAL-1 at very early time postopera-
tively. GAL-1 is cardio protective as it plays a 
critical role in controlling acute inflammation 
[31], apoptosis [32, 33] and neovascularization 
[34]. Its upregulation possibly can be a part of 
survival mechanism to protect the heart after 
surgical insult. GAL-1 is also part of the hypoxia-
regulated transcriptome [14, 35], and a compo-
nent of the contractile apparatus in cardiomyo-
cytes [36] suggesting a potential role in 
modulating cardiac function. GAL-1 up regula-
tion in the heart after surgical manipulation can 
Galectin-1 in surgical stress
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have important implications in the postopera-
tive recovery phase [37, 38]. The therapeutic 
administration or modulation of its expression 
in cardiac tissue can present as a potential 
novel strategy to prevent postoperative 
complications.
In conclusion, GAL-1 is valuable biomarker of 
surgical stress. More work is needed to clarify 
further the role of GAL-1 as a stress marker for 
surgical trauma particularly related to open 
heart procedures. This work has opened a 
small window for looking at GAL-1 from a new 
perspective.
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